A myelin gene causative of a catatonia‐depression syndrome upon aging
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Severe mental illnesses have been linked to white matter abnormalities, documented by postmortem studies. However, cause and effect have remained difficult to distinguish. CNP (2′,3′‐cyclic nucleotide 3′‐phosphodiesterase) is among the oligodendrocyte/myelin‐associated genes most robustly reduced on mRNA and protein level in brains of schizophrenic, bipolar or major depressive patients. This suggests that CNP reduction might be critical for a more general disease process and not restricted to a single diagnostic category. We show here that reduced expression of CNP is the primary cause of a distinct behavioural phenotype, seen only upon aging as an additional ‘pro‐inflammatory hit’. This phenotype is strikingly similar in Cnp heterozygous mice and patients with mental disease carrying the AA genotype at CNP SNP rs2070106. The characteristic features in both species with their partial CNP ‘loss‐of‐function’ genotype are best described as ‘catatonia‐depression’ syndrome. As a consequence of perturbed CNP expression, mice show secondary low‐grade inflammation/neurodegeneration. Analogously, in man, diffusion tensor imaging points to axonal loss in the frontal corpus callosum. To conclude, subtle white matter abnormalities inducing neurodegenerative changes can cause/amplify psychiatric diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Developments of a water-maze procedure for studying spatial learning in the rat
Morris, R. (1984) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(84)90007-4 · Cited by 7,180 · cited 1×
“…test for olfaction (Radyushkin et al, 2009), floating behaviour (analysis of swimming/ floating during a 90s trial in the Morris water maze pool; Morris, 1984; Stone & Lin, 2011), tail suspension test (Cryan et al, 2005), bar test (Kuschinsky & Hornykiewicz, 1972; see Fig 2P and videos of…”
The brief symptom inventory: an introductory report.
Derogatis, L. R., & Melisaratos, N. (1983) · Psychological Medicine · doi:10.1017/s0033291700048017 · Cited by 6,650
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
Kimchi-Sarfaty, C., Oh, J. M., Kim, I.-W., Sauna, Z. E., Calcagno, A. M., Ambudkar, S. V., & Gottesman, M. M. (2007) · Science · doi:10.1126/science.1135308 · Cited by 2,416
Moy, S. S., Nadler, J. J., Perez, A., Barbaro, R. P., Johns, J. M., Magnuson, T. R., Piven, J., & Crawley, J. N. (2004) · Genes, Brain and Behavior · doi:10.1111/j.1601-1848.2004.00076.x · Cited by 1,522
MYELINATION IN RAT BRAIN: METHOD OF MYELIN ISOLATION1
Norton, W. T., & Poduslo, S. E. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb07519.x · Cited by 1,413 · cited 1×
“Myelin purified from protein lysates was performed according to (Norton & Poduslo, 1973).”
Inflammation in neurodegenerative diseases
Amor, S., Puentes, F., Baker, D., & Van Der Valk, P. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03225.x · Cited by 1,355
Identification of loci associated with schizophrenia by genome-wide association and follow-up
Molecular Genetics of Schizophrenia Collaboration, O'Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V., Nikolov, I., Hamshere, M., Carroll, L., et al. (2008) · Nature Genetics · doi:10.1038/ng.201 · Cited by 1,070
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., Griffiths, I. R., & Nave, K.-A. (2003) · Nature Genetics · doi:10.1038/ng1095 · Cited by 1,036 · cited 4×
“…an important cofactor, supporting the view that the underlying mechanism of this mental syndrome is a slowly progressive neurodegeneration, beginning in subcortical white matter, as described for the more rapid axonal loss in Cnp null mutant mice (Edgar et al, 2009; Lappe-Siefke et al, 2003).”
InfluentialSelf-citationWhite Matter Changes in Schizophrenia: Evidence for Myelin-Related Dysfunction
Davis, K. L., Stewart, D. G., Friedman, J. I., Buchsbaum, M., Harvey, P. D., Hof, P. R., Buxbaum, J., & Haroutunian, V. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.5.443 · Cited by 793
Cytokines and schizophrenia: microglia hypothesis of schizophrenia
Monji, A., Kato, T., & Kanba, S. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01945.x · Cited by 508 · cited 2×
“Recent work indicates that in major psychiatric disorders like schizophrenia and depression, low-grade inflammation constitutes a crucial mechanism in the final common disease pathway (reviewed in Monji et al, 2009).”
Cited by
Myelination of the Nervous System: Mechanisms and Functions
Nave, K.-A., & Werner, H. B. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100913-013101 · Cited by 983
Self-citationOligodendrocytes: Myelination and Axonal Support
Simons, M., & Nave, K.-A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020479 · Cited by 864
Self-citationHagemeyer, N., Hanft, K.-M., Akriditou, M.-A., Unger, N., Park, E. S., Stanley, E. R., Staszewski, O., Dimou, L., & Prinz, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1747-1 · Cited by 558
Self-citationGacias, M., Gaspari, S., Santos, P.-M. G., Tamburini, S., Andrade, M., Zhang, F., Shen, N., Tolstikov, V., Kiebish, M. A., Dupree, J. L., et al. (2016) · eLife · doi:10.7554/elife.13442 · Cited by 308
Structure and neural mechanisms of catatonia
Walther, S., Stegmayer, K., Wilson, J. E., & Heckers, S. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30474-7 · Cited by 315
Self-citationMicroglia and the brain: Complementary partners in development and disease
Hammond, T. R., Robinton, D., & Stevens, B. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100616-060509 · Cited by 288
Liu, J., Dupree, J. L., Gacias, M., Frawley, R., Sikder, T., Naik, P., & Casaccia, P. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3608-15.2016 · Cited by 274
Myelin dynamics: protecting and shaping neuronal functions
Saab, A. S., & Nave, K.-A. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.09.013 · Cited by 259
Self-citationMadsen, P. M., Motti, D., Karmally, S., Szymkowski, D. E., Lambertsen, K. L., Bethea, J. R., & Brambilla, R. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0211-16.2016 · Cited by 161
Myelination and Oligodendrocyte Functions in Psychiatric Diseases
Nave, K.-A., & Ehrenreich, H. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.189 · Cited by 157
Self-citationActivated microglia drive demyelination via CSF1R signaling
Marzan, D. E., Brügger‐Verdon, V., West, B. L., Liddelow, S., Samanta, J., & Salzer, J. L. (2021) · Glia · doi:10.1002/glia.23980 · Cited by 172
“Mice deficient for 20 ,30-Cyclic Nucleotide 30 Phosphodiesterase (Cnp) have minor myelin abnormalities but exhibit low grade inflammation and neurobehavioral disorders (Hagemeyer et al., 2012) that are improved upon depletion of microglia with PLX (Janova et al., 2018).”
BackgroundMicroglia ablation alleviates myelin-associated catatonic signs in mice
Janova, H., Arinrad, S., Balmuth, E., Mitjans, M., Hertel, J., Habes, M., Bittner, R. A., Pan, H., Goebbels, S., Begemann, M., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci97032 · Cited by 107
“We note, however, that diffusion tensor imaging identified higher axial diffusivity and a higher apparent diffusion coefficient in the frontal part of the corpus callosum of AA as compared with GG subjects, consistent with a more progressed axonal loss/degeneration (11).”
BackgroundResultInfluentialSelf-citationCathomas, F., Azzinnari, D., Bergamini, G., Sigrist, H., Buerge, M., Hoop, V., Wicki, B., Goetze, L., Soares, S., Kukelova, D., et al. (2019) · Genes, Brain and Behavior · doi:10.1111/gbb.12475 · Cited by 78
Self-citationProgressive axonopathy when oligodendrocytes lack the myelin protein CMTM5
Buscham, T. J., Eichel-Vogel, M. A., Steyer, A. M., Jahn, O., Strenzke, N., Dardawal, R., Memhave, T. R., Siems, S. B., Müller, C., Meschkat, M., et al. (2022) · eLife · doi:10.7554/elife.75523 · Cited by 18
Self-citationMarzan, D. E., West, B. L., & Salzer, J. L. (2018) · doi:10.1101/501148 · Cited by 4
Nanobodies against the myelin enzyme CNPase as tools for structural and functional studies
Markusson, S., Raasakka, A., Schröder, M., Sograte‐Idrissi, S., Rahimi, A. M., Asadpour, O., Körner, H., Lodygin, D., Eichel‐Vogel, M. A., Chowdhury, R., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16274 · Cited by 1
Metadata
- Authors
- Hagemeyer, N., Goebbels, S., Papiol, S., Kästner, A., Hofer, S., Begemann, M., Gerwig, U. C., Boretius, S., Wieser, G. L., Ronnenberg, A., Gurvich, A., Heckers, S. H., Frahm, J., Nave, K., & Ehrenreich, H.
- Venue
- EMBO Molecular Medicine
- Published
- 2012-04-04
- Volume
- 4
- Issue
- 6
- Pages
- 528-539
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2157860240
- Cited by
- 130
- References
- 15
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.